(Total Views: 418)
Posted On: 09/30/2019 5:46:22 PM
Post# of 148936
Because with BTD designation, stability data requirements would be waived, saving us a month or so. If it was such an absurd thing, then Nader wouldn't have stressed it couple of weeks ago... ("immediately apply"
This is a breakthrough, so it should get the formal designation of a breakthrough, especially if we get the stability data advantage.
We already are eligible for priority review via fast-track designation.
I think FDA denied ORPHAN DRUG designation.
This is a breakthrough, so it should get the formal designation of a breakthrough, especially if we get the stability data advantage. We already are eligible for priority review via fast-track designation.
I think FDA denied ORPHAN DRUG designation.
(0)
(0)Scroll down for more posts ▼
